Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Hypertension and heart failure are important contributors to global morbidity and mortality. Despite therapeutic lifestyle and pharmacological measures, a significant proportion of people with hypertension do not reach treatment targets. Patients with resistant or poorly controlled hypertension are...

Full description

Bibliographic Details
Main Authors:	Anna Meta Dyrvig Kristensen, Manan Pareek, Michael Hecht Olsen, Deepak L Bhatt
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2020-02-01
Series:	US Cardiology Review
Online Access:	https://www.uscjournal.com/articleindex/usc.2019.13.2

Similar Items

Myocardial infarction with simultaneous anterior and inferior ST‐segment elevation
by: Anna Meta Dyrvig Kristensen, et al.
Published: (2019-03-01)

Conservatively managed saddle pulmonary embolism
by: Anna Meta Dyrvig Kristensen, et al.
Published: (2019-06-01)

Effect of baroreflex activation therapy on dipping pattern in patients with resistant hypertension
by: Manuel Wallbach, et al.
Published: (2023-01-01)

Baroreflex Activation Therapy for the Treatment of Drug-Resistant Hypertension: New Developments
by: Teba Alnima, et al.
Published: (2012-01-01)

Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertension
by: Ann‐Kathrin Schäfer, et al.
Published: (2021-07-01)

Respiratory patterns and baroreflex function in heart failure
by: Alberto Radaelli, et al.
Published: (2023-02-01)

Baroreflex activation therapy in advanced heart failure: A long‐term follow‐up
by: Dong Wang, et al.
Published: (2025-02-01)

Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States
by: John Bisognano, et al.
Published: (2021-03-01)

Baroreflex sensitivity in patients with chronic heart failure: the clinical significance and impact of therapy
by: Mikhail Viktorovich Nepoklonov, et al.
Published: (2010-12-01)

Baroreflex activation therapy in advanced heart failure therapy: insights from a real‐world scenario
by: Denise Guckel, et al.
Published: (2023-02-01)

Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review
by: Juan Máximo Molina‐Linde, et al.
Published: (2023-10-01)

An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany
by: Oleg Borisenko, et al.
Published: (2018-08-01)

Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience
by: Carola Blanco, et al.
Published: (2023-12-01)

Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy
by: Pia I. Nottebohm, et al.
Published: (2022-10-01)

In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension.
by: John S Clemmer, et al.
Published: (2021-01-01)

In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension
by: John S. Clemmer, et al.
Published: (2021-01-01)

The Effect of Physical Resistance Training on Baroreflex Sensitivity of Hypertensive Rats
by: Moisés Felipe Pereira Gomes, et al.

Baroreflex control of sympathetic activity in experimental hypertension
by: M.C.C. Irigoyen, et al.
Published: (1998-09-01)

The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT study*
by: Daniel Gordin, et al.
Published: (2017-09-01)

Efficacy and safety of baroreflex activation therapy for treatment of resistant hypertension: a systematic review and meta-analysis
by: Wang Chunbin, et al.
Published: (2018-08-01)

Baroreflex activation therapy for heart failure with reduced ejection fraction: A comprehensive systematic review and meta-analysis
by: Ruijie Shi, et al.
Published: (2024-01-01)

Arterial baroreflex sensitivity: Relationship with peripheral chemoreflex in patients with chronic heart failure
by: Nikita Trembach, et al.
Published: (2018-10-01)

Acute Effects of Vagotomy on Baroreflex Equilibrium Diagram in Rats with Chronic Heart Failure
by: Toru Kawada, et al.
Published: (2016-08-01)

Making sense of subclinical cardiac alterations in patients with diabetes
by: Manan Pareek, et al.
Published: (2019-11-01)

Alcohol and blood pressure
by: Manan Pareek, et al.
Published: (2017-02-01)

A sham-controlled randomised pilot trial on baroreflex activation therapy in patients with resistant hypertension: What will the future hold?
by: D. Gordin, et al.
Published: (2024-12-01)

Calibration of Baroreflex Equilibrium Diagram Based on Exogenous Pressor Agents in Chronic Heart Failure Rats
by: Toru Kawada, et al.
Published: (2015-01-01)

Calibration of Baroreflex Equilibrium Diagram Based on Exogenous Pressor Agents in Chronic Heart Failure Rats
by: Toru Kawada, et al.
Published: (2015-02-01)

Sympathetic activation and baroreflex function during intradialytic hypertensive episodes.
by: Dvora Rubinger, et al.
Published: (2012-01-01)

Impact of medication adherence on the efficacy of Baroreflex activation therapy
by: Ann‐Kathrin C. Schäfer, et al.
Published: (2022-08-01)

The arterial baroreflex effectiveness index in risk stratification of chronic heart failure patients who are candidates for cardiac resynchronization therapy
by: João Fernandes Serôdio, et al.
Published: (2016-06-01)

Effects of baroreflex activation therapy on cardiac function and morphology
by: Ann‐Kathrin C. Schäfer, et al.
Published: (2024-10-01)

Variations of perioperative baroreflex sensitivity in hypertensive and normotensive patients
by: Dan Huang, et al.
Published: (2017-01-01)

Cardiac Baroreflex, HRV, and Statistics: An Interdisciplinary Approach in Hypertension
by: Nadia Solaro, et al.
Published: (2019-04-01)

Intracranial baroreflex is attenuated in an ovine model of renovascular hypertension
by: Sydney Vari, et al.
Published: (2021-03-01)

Peripheral Resistance Baroreflex During Incremental Bicycle Ergometer Exercise: Characterization and Correlation With Cardiac Baroreflex
by: Alberto Porta, et al.
Published: (2018-06-01)

nNOS gene transfer to RVLM improves baroreflex function in rats with chronic heart failure.
by: Wang, Y, et al.
Published: (2003)

Impaired Baroreflex Function in an Ovine Model of Chronic Heart Failure Induced by Multiple Coronary Microembolizations
by: Yonis Abukar, et al.
Published: (2019-11-01)

Volatile Blood Pressure Due To Baroreflex and Autonomic Failure
by: Verena Adelina Briner, et al.
Published: (2014-10-01)

Differences in the Sensitivity of the Baroreflex of Heart Rate Regulation to Local Geomagnetic Field Variations in Normotensive and Hypertensive Humans
by: Liliya Poskotinova, et al.
Published: (2022-07-01)